Company Filing History:
Years Active: 2011-2017
Title: Hiroshi Ikeda: Innovator in Immunohistochemical Staining and Silicon Ingot Manufacturing
Introduction
Hiroshi Ikeda, a prominent inventor based in Akita, Japan, holds three patents that contribute significantly to the fields of immunohistochemistry and silicon manufacturing. His innovative approaches have propelled advancements in both medical and industrial applications.
Latest Patents
Hiroshi Ikeda's latest patents showcase his expertise in automation and advanced methodologies. The first patent, titled "Apparatus for automatic electric field immunohistochemical staining and method for automatic electric field immunohistochemical staining," presents a sophisticated system designed to enhance the acceleration and automation of immunohistochemical staining. This apparatus features a sample mounting unit for glass substrates, a solution supply unit, an electric field stirring unit, and a washing unit working in unison to activate antigens and facilitate antigen-antibody reactions.
In addition, his patent for the "Method for manufacturing polycrystalline silicon ingot" describes a unique process of unidirectionally solidifying molten silicon within a crucible lined with silica. This innovative method divides the solidification process into distinct height zones, optimizing solidification rates for improved ingot quality.
Career Highlights
Hiroshi Ikeda has garnered valuable experience through his work with reputable organizations, including Mitsubishi Materials Corporation and Mitsubishi Materials Electronic Chemicals Co., Ltd. His tenure at these companies has allowed him to hone his skills in both research and practical applications within the materials science field.
Collaborations
Throughout his career, Ikeda has collaborated with esteemed colleagues such as Saburo Wakita and Kouji Tsuzukihashi. These partnerships have enriched his research endeavors, furthering innovation and success in his projects.
Conclusion
Hiroshi Ikeda stands out as a visionary inventor whose contributions are shaping the future of immunohistochemistry and silicon manufacturing. His patents reflect a commitment to advancing technology and improving methodologies in these critical fields.